Answers are grounded in this paper and cite their sources.
Chemosaturation with percutaneous hepatic perfusion (CS-PHP) using melphalan is frequently associated with profound hypotension, necessitating high-dose norepinephrine support. We investigated the potential of the extracorporeal chemofilter to remove circulating norepinephrine. In this prospective observational study, paired blood samples were obtained upstream and downstream of the extracorporeal filter during CS-PHP at predefined procedural timepoints. Norepinephrine was quantified using liquid chromatography–tandem mass spectrometry. Transfilter concentration reduction was assessed in conjunction with temporal changes in norepinephrine administration during the procedure. A total of ten CS-PHP procedures in eight patients were analyzed. This included the main test, for which one procedure was performed on each patient (n = 8), as well as an additional test on one patient, for which two additional procedures were performed to enable an intra-individual assessment of three consecutive procedures. Circulating norepinephrine concentrations increased during treatment, peaking upstream of the filter during active filtration. The filter reduced norepinephrine concentrations by a median of 91.3% after bypass closure and 91.9% during melphalan perfusion (both p = 0.008). Norepinephrine infusion rates increased from a median of 0.2 μg/kg/min after inferior vena cava occlusion to 0.6 μg/kg/min immediately after filter activation ( p < 0.01). These rates remained elevated throughout filtration before decreasing after completion of the procedure. The temporal relationship between transfilter concentration reduction of norepinephrine and a significant increase in norepinephrine administration suggests an association with hemodynamic effects during CS-PHP.
No takes yet. Share an insight, caveat, or question.
Ebel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: